Arbutus Biopharma Stock Forecast - Rate Of Daily Change
| ABUS Stock | USD 2.97 0.06 2.06% |
Arbutus Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Arbutus Biopharma stock prices and determine the direction of Arbutus Biopharma Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Arbutus Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Arbutus Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Arbutus Biopharma's systematic risk associated with finding meaningful patterns of Arbutus Biopharma fundamentals over time.
Check out Historical Fundamental Analysis of Arbutus Biopharma to cross-verify your projections. Arbutus |
Open Interest Against 2024-04-19 Arbutus Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Arbutus Biopharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Arbutus Biopharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Arbutus Biopharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Arbutus Biopharma's open interest, investors have to compare it to Arbutus Biopharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Arbutus Biopharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Arbutus. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Arbutus Biopharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Arbutus Biopharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Arbutus Biopharma's price structures and extracts relationships that further increase the generated results' accuracy.
Rate Of Daily Change (RDOC) indicator calculates rate of change of a given period over the current closing price of Arbutus Biopharma.| Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
| 1.02 | 1.02 |
| Check Arbutus Biopharma Volatility | Backtest Arbutus Biopharma | Information Ratio |
Arbutus Biopharma Trading Date Momentum
| On April 16 2024 Arbutus Biopharma Corp was traded for 2.97 at the closing time. The top price for the day was 2.99 and the lowest listed price was 2.82 . There was no trading activity during the period 0.0. Lack of trading volume on April 16, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.36% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
| Compare Arbutus Biopharma to competition |
Other Forecasting Options for Arbutus Biopharma
For every potential investor in Arbutus, whether a beginner or expert, Arbutus Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Arbutus Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Arbutus. Basic forecasting techniques help filter out the noise by identifying Arbutus Biopharma's price trends.Arbutus Biopharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Arbutus Biopharma stock to make a market-neutral strategy. Peer analysis of Arbutus Biopharma could also be used in its relative valuation, which is a method of valuing Arbutus Biopharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Arbutus Biopharma Corp Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Arbutus Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Arbutus Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Arbutus Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Arbutus Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arbutus Biopharma shares will generate the highest return on investment. By undertsting and applying Arbutus Biopharma stock market strength indicators, traders can identify Arbutus Biopharma Corp entry and exit signals to maximize returns.
Arbutus Biopharma Risk Indicators
The analysis of Arbutus Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Arbutus Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting arbutus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.99 | |||
| Semi Deviation | 1.7 | |||
| Standard Deviation | 3.06 | |||
| Variance | 9.34 | |||
| Downside Variance | 4.26 | |||
| Semi Variance | 2.89 | |||
| Expected Short fall | (2.70) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Arbutus Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arbutus Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arbutus Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against Arbutus Stock
| 0.74 | BIIB | Biogen Inc Financial Report 23rd of April 2024 | PairCorr |
| 0.69 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |
| 0.57 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.48 | JNJ | Johnson Johnson Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Arbutus Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arbutus Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arbutus Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arbutus Biopharma Corp to buy it.
The correlation of Arbutus Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arbutus Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arbutus Biopharma Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arbutus Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Arbutus Biopharma to cross-verify your projections. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Arbutus Stock analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Arbutus Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arbutus Biopharma. If investors know Arbutus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arbutus Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.44) | Revenue Per Share 0.109 | Quarterly Revenue Growth (0.66) | Return On Assets (0.29) | Return On Equity (0.60) |
The market value of Arbutus Biopharma Corp is measured differently than its book value, which is the value of Arbutus that is recorded on the company's balance sheet. Investors also form their own opinion of Arbutus Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arbutus Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arbutus Biopharma's market value can be influenced by many factors that don't directly affect Arbutus Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arbutus Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Arbutus Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arbutus Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.